Indegene Limited has informed the Exchange about Agreements
INDGN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Indegene Limited has informed the exchange that its UK subsidiary, Indegene Healthcare UK Limited, signed a Trade and Asset Purchase Agreement on April 1, 2026 to buy the trade and business (as a going concern) of Trilogy Writing and Consulting Limited for GBP 1,90,679. Both the buyer and seller are indirectly wholly owned by Indegene Limited, making this an internal group restructuring. The buyer had already acquired 100% of the seller's share capital via a prior intimation dated March 1, 2026. The transaction qualifies as a related party transaction and is being carried out at arm's length basis with no special rights involved.
This is an internal group restructuring with a very small deal size (GBP ~190K), so it has minimal direct impact on shareholders. It does not trigger any open offer obligation and is unlikely to move the stock price. The move appears to consolidate assets within the Indegene group structure.